Pfizer's Stock Just Dropped 6%. Can the Pharmaceutical Giant Bounce Back in 2026? [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Even if Pfizer's stock doesn't rebound in 2026, investors can find some bright spots. 10 stocks we like better than Pfizer › A rising tide doesn't lift all boats. For example, a boat with gaping holes in its hull will sink regardless of how high the tide rises. Pfizer (NYSE: PFE) seemed to be the investing equivalent of such a boat in 2025. Shares of the pharmaceutical giant declined 6% last year, experiencing several significant fluctuations along the way. Can Pfizer's stock bounce back in 2026? It's entirely possible that Pfizer stock will indeed rebound this year. Perhaps the most likely reason for a bounce is the potential for positive clinical results that excite investors. Many will particularly watch data from Metsera's obesity drug, MET-097i. Pfizer completed its acquisition of the company in November 2025. The deal added Metsera's promising obesity drug programs to Pfizer's pipeline. Results from the Phase 2b Vesper-2 and Vesper-3 clinical studies evaluating MET-09
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- GSK to buy RAPT Therapeutics in $2.2 billion deal for promising food allergy therapy [Yahoo! Finance]Yahoo! Finance
- Down 55%, Should You Buy the Dip on Pfizer? [Yahoo! Finance]Yahoo! Finance
- MoneyShow's Best Investment Ideas For 2026: Part 7 [Seeking Alpha]Seeking Alpha
- Could Pfizer Inc.'s (NYSE:PFE) Weak Financials Mean That The Market Could Correct Its Share Price? [Yahoo! Finance]Yahoo! Finance
- Pfizer (PFE) CEO Isn't Ready For A Fight With RFK Jr., Says Jim Cramer [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 1/16/26 - Form 4
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- PFE's page on the SEC website